drugset / Trial / NCT04443868
Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blinded, placebo-controlled parallel, phase II clinical efficacy study evaluating Nitric Oxide Nasal Irrigation (NONI) for the treatment of COVID-19 in individuals with mild COVID-19 Infection.
Timeline
- Start
- 2021-01
- Primary completion
- 2021-04
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 14.4 ppm | Intranasal |
| Subject | Nitric Oxide | Other / unclassified | 240 ml | Intranasal |